JP2009539914A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539914A5
JP2009539914A5 JP2009514716A JP2009514716A JP2009539914A5 JP 2009539914 A5 JP2009539914 A5 JP 2009539914A5 JP 2009514716 A JP2009514716 A JP 2009514716A JP 2009514716 A JP2009514716 A JP 2009514716A JP 2009539914 A5 JP2009539914 A5 JP 2009539914A5
Authority
JP
Japan
Prior art keywords
alkyl
group
hydrogen
preferably selected
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009514716A
Other languages
English (en)
Japanese (ja)
Other versions
JP5475442B2 (ja
JP2009539914A (ja
Filing date
Publication date
Priority claimed from EP06090109A external-priority patent/EP1867648A1/en
Application filed filed Critical
Priority claimed from PCT/EP2007/005432 external-priority patent/WO2007144204A1/en
Publication of JP2009539914A publication Critical patent/JP2009539914A/ja
Publication of JP2009539914A5 publication Critical patent/JP2009539914A5/ja
Application granted granted Critical
Publication of JP5475442B2 publication Critical patent/JP5475442B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009514716A 2006-06-13 2007-06-12 置換されたアミノピラゾロピリン類及びそれらの塩類、それらの調製及びそれらを含んで成る医薬組成物類 Expired - Fee Related JP5475442B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06090109.7 2006-06-13
EP06090109A EP1867648A1 (en) 2006-06-13 2006-06-13 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.
EP07090020.4 2007-02-15
EP07090020 2007-02-15
PCT/EP2007/005432 WO2007144204A1 (en) 2006-06-13 2007-06-12 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them

Publications (3)

Publication Number Publication Date
JP2009539914A JP2009539914A (ja) 2009-11-19
JP2009539914A5 true JP2009539914A5 (https=) 2010-07-29
JP5475442B2 JP5475442B2 (ja) 2014-04-16

Family

ID=38445661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009514716A Expired - Fee Related JP5475442B2 (ja) 2006-06-13 2007-06-12 置換されたアミノピラゾロピリン類及びそれらの塩類、それらの調製及びそれらを含んで成る医薬組成物類

Country Status (21)

Country Link
US (1) US7846928B2 (https=)
EP (1) EP2061790B1 (https=)
JP (1) JP5475442B2 (https=)
KR (1) KR20090018212A (https=)
AR (1) AR061346A1 (https=)
AU (1) AU2007260216A1 (https=)
BR (1) BRPI0711961A2 (https=)
CA (1) CA2654789C (https=)
CL (1) CL2007001711A1 (https=)
CR (1) CR10505A (https=)
EA (1) EA200802407A1 (https=)
EC (1) ECSP088963A (https=)
ES (1) ES2515117T3 (https=)
GT (1) GT200800285A (https=)
IL (1) IL195813A0 (https=)
MX (1) MX2008015955A (https=)
NO (1) NO20090171L (https=)
PE (1) PE20080205A1 (https=)
TW (1) TW200815438A (https=)
UY (1) UY30409A1 (https=)
WO (1) WO2007144204A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20061119A1 (es) * 2005-01-19 2006-11-27 Aventis Pharma Sa PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie
TW200924762A (en) * 2007-11-02 2009-06-16 Vertex Pharma Kinase inhibitors
JP2011520809A (ja) * 2008-05-05 2011-07-21 アムジエン・インコーポレーテツド γセクレターゼモジュレーターとしての尿素化合物
EP2307456B1 (en) 2008-06-27 2014-10-15 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
WO2010059788A1 (en) 2008-11-20 2010-05-27 Genentech, Inc. Pyrazolopyridine pi3k inhibitor compounds and methods of use
US8846673B2 (en) 2009-08-11 2014-09-30 Bristol-Myers Squibb Company Azaindazoles as kinase inhibitors and use thereof
WO2011076744A1 (en) 2009-12-21 2011-06-30 Novartis Ag Disubstituted heteroaryl-fused pyridines
EP2831072B1 (en) * 2012-03-26 2017-04-19 Arroyo BioSciences L.L.C. Novel sphingosine 1-phosphate receptor antagonists
WO2013188848A2 (en) * 2012-06-15 2013-12-19 The Regents Of The University Of California Antiviral compounds and methods of use
WO2017053604A1 (en) 2015-09-23 2017-03-30 The Regents Of The University Of California Potent antiviral pyrazolopyridine compounds
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
AU2018346597B2 (en) 2017-10-06 2023-07-13 Forma Therapeutics, Inc. Inhibiting Ubiquitin Specific Peptidase 30
JP7050165B2 (ja) 2018-02-26 2022-04-07 ギリアード サイエンシーズ, インコーポレイテッド Hbv複製阻害剤としての置換ピロリジン化合物
JP7449242B2 (ja) 2018-05-17 2024-03-13 フォーマ セラピューティクス,インコーポレイテッド ユビキチン特異的ペプチダーゼ30(usp30)阻害剤として有用な縮合二環化合物
JP7530889B2 (ja) 2018-10-05 2024-08-08 フォーマ セラピューティクス,インコーポレイテッド ユビキチン特異的プロテアーゼ30(usp30)阻害剤として作用する縮合ピロリン
TW202136238A (zh) * 2020-01-06 2021-10-01 大陸商廣東東陽光藥業有限公司 RORγt抑制劑及其製備方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670364B2 (en) * 2001-01-31 2003-12-30 Telik, Inc. Antagonists of MCP-1 function and methods of use thereof
DK1638941T3 (da) * 2003-05-22 2010-10-11 Abbott Lab Indazol-, benzisoxazol- og benzisothiazolkinaseinhibitorer
JP2007515474A (ja) * 2003-12-22 2007-06-14 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド Crf受容体アンタゴニストおよびそれらに関連する方法
FR2876691B1 (fr) * 2004-10-18 2006-12-29 Sanofi Aventis Sa Derives de pyridine, leur preparation, leur application en therapeutique
ATE554087T1 (de) * 2004-10-29 2012-05-15 Abbott Lab Neue kinaseinhibitoren
PE20061119A1 (es) * 2005-01-19 2006-11-27 Aventis Pharma Sa PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie
EP1683796A1 (en) * 2005-01-24 2006-07-26 Schering Aktiengesellschaft Pyrazolopyridines, their preparation and their medical use
DK1899333T3 (da) * 2005-06-27 2009-06-15 Sanofi Aventis Pyrazolopyridinderivater som inhibitorer af beta-adrenerg receptor-kinase 1

Similar Documents

Publication Publication Date Title
JP2009539914A5 (https=)
JP2009539912A5 (https=)
JP2010523596A5 (https=)
JP2012520247A5 (https=)
JP2006096962A5 (https=)
JP2011121940A5 (ja) 発光素子
JP2009062537A5 (https=)
RU2011101140A (ru) Пирроло[2,3-b]пиридиновые производные в качестве ингибиторов протеинкиназ
JP2013040159A5 (ja) 有機金属錯体
DE602005023185D1 (de) Prodrugs mit neuen biospaltbaren verbindern
DE602005010804D1 (de) Herstellung von Metallverbindungen der 12. und 13. Gruppe, die niedrige Mengen an Sauerstoff-enthaltenden Verunreinigungen aufweisen
MX2007012090A (es) Derivados sustituidos de pirazoliloxifenilo como herbicidas.
JP2010504908A5 (https=)
JP2009541403A5 (https=)
JP2013509487A5 (https=)
JP2010520851A5 (https=)
JP2006508036A5 (https=)
JP2005515295A5 (https=)
JP2012092103A5 (https=)
JP2013506729A5 (https=)
JP2007523941A5 (https=)
DE502005011078D1 (de) Herstellung von 3-pentennitril aus 1,3-butadien
JP2004535412A5 (https=)
JP2020504434A5 (https=)
JP2015510508A5 (https=)